Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical management of breast cancer heterogeneity.
Zardavas D, Irrthum A, Swanton C, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2015 Jul;12(7):381-94. doi: 10.1038/nrclinonc.2015.73. Epub 2015 Apr 21. Nat Rev Clin Oncol. 2015. PMID: 25895611 Review.
Emerging targeted agents in metastatic breast cancer.
Zardavas D, Baselga J, Piccart M. Zardavas D, et al. Nat Rev Clin Oncol. 2013 Apr;10(4):191-210. doi: 10.1038/nrclinonc.2013.29. Epub 2013 Mar 5. Nat Rev Clin Oncol. 2013. PMID: 23459626 Review.
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.
de Azambuja E, Zardavas D, Lemort M, Rossari J, Moulin C, Buttice A, D'Hondt V, Lebrun F, Lalami Y, Cardoso F, Sotiriou C, Gil T, Devriendt D, Paesmans M, Piccart-Gebhart M, Awada A. de Azambuja E, et al. Among authors: zardavas d, d hondt v. Ann Oncol. 2013 Dec;24(12):2985-9. doi: 10.1093/annonc/mdt359. Epub 2013 Sep 7. Ann Oncol. 2013. PMID: 24013582 Clinical Trial.
Clinical practice-changing trials: the HERA study paradigm.
Zardavas D, Ades F, de Azambuja E. Zardavas D, et al. Expert Rev Anticancer Ther. 2013 Nov;13(11):1249-56. doi: 10.1586/14737140.2013.848168. Epub 2013 Oct 21. Expert Rev Anticancer Ther. 2013. PMID: 24138446 Review.
Anticancer drug development: moving away from the old habits.
Ades F, Zardavas D, Aftimos P, Awada A. Ades F, et al. Among authors: zardavas d. Curr Opin Oncol. 2014 May;26(3):334-9. doi: 10.1097/CCO.0000000000000076. Curr Opin Oncol. 2014. PMID: 24614094 No abstract available.
57 results